A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
Clinical trial NCT04418765 · COMPLETED
Trial details
- NCT number
- NCT04418765
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2021-07-15
- Enrollment
- 892
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.